Mereo BioPharma (MREO) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.29 -3.33%
Financial Fact:
Gross profit (loss): 21.36K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Gross profit (loss): 21.36K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Mereo BioPharma (NASDAQ: MREO) reported Q2 EPS of ($0.01), in-line with the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood Ventures Fund II opens at $22.50, IPO at $25
- Lode Gold names Qi Guo to its board of directors
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
